Response to Letter to the Editor From Bouwmeester RN et al.: "Eculizumab in Postransplant TMA: Unproven Benefit.".
作者信息
Maritati Federica, La Manna Gaetano, Comai Giorgia
机构信息
Nephrology, Dialysis and Kidney Transplant Unit, IRCCS-Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum-University of Bologna, Bologna, Italy.
出版信息
Kidney Int Rep. 2024 Apr 7;9(6):1930-1931. doi: 10.1016/j.ekir.2024.04.013. eCollection 2024 Jun.
Abstract
摘要
相似文献
1
Response to Letter to the Editor From Bouwmeester RN et al.: "Eculizumab in Postransplant TMA: Unproven Benefit.".对Bouwmeester RN等人致编辑信的回复：“依库珠单抗治疗移植后血栓性微血管病：益处未得到证实” 。
Kidney Int Rep. 2024 Apr 7;9(6):1930-1931. doi: 10.1016/j.ekir.2024.04.013. eCollection 2024 Jun.
2
Eculizumab in Posttransplant TMA: Unproven Benefit: A Response to Maritati et al.: "Eculizumab First" in the Management of Posttransplant Thrombotic Microangiopathy.依库珠单抗治疗移植后血栓性微血管病：益处未得到证实：对马里蒂等人《移植后血栓性微血管病管理中的“先使用依库珠单抗”》的回应
Kidney Int Rep. 2024 Apr 8;9(6):1929. doi: 10.1016/j.ekir.2024.02.1442. eCollection 2024 Jun.
3
Thrombotic Microangiopathy Following Pediatric Autologous Hematopoietic Cell Transplantation: A Report of Significant End-Organ Dysfunction in Eculizumab-Treated Survivors.儿童自体造血细胞移植后血栓性微血管病：依库珠单抗治疗幸存者发生重要终末器官功能障碍的报告。
Biol Blood Marrow Transplant. 2019 May;25(5):e163-e168. doi: 10.1016/j.bbmt.2018.12.840. Epub 2019 Jan 11.
4
Eculizumab in the management of drug-induced thrombotic microangiopathy: A scoping review of the literature.依库珠单抗治疗药物诱导的血栓性微血管病：文献综述范围。
Thromb Res. 2023 Apr;224:73-79. doi: 10.1016/j.thromres.2023.02.012. Epub 2023 Mar 2.
5
Response to Letter to the Editor From Ville S. et al. About: "Eculizumab First" in the Management of Posttransplant Thrombotic Microangiopathy.对Ville S.等人致编辑信的回复。主题：移植后血栓性微血管病管理中的“依库珠单抗优先”
Kidney Int Rep. 2024 Mar 27;9(6):1933-1934. doi: 10.1016/j.ekir.2024.03.029. eCollection 2024 Jun.
6
Application of a scoring system in Japanese patients diagnosed with atypical hemolytic uremic syndrome to assess the relationship between the score and clinical responses to eculizumab.评分系统在诊断为非典型溶血尿毒综合征的日本患者中的应用，以评估评分与依库珠单抗临床反应之间的关系。
Thromb J. 2023 Apr 18;21(1):43. doi: 10.1186/s12959-023-00489-0.
7
Efficacy and Safety of Eculizumab in the Treatment of Transplant-Associated Thrombotic Microangiopathy: A Systematic Review and Meta-Analysis.依库珠单抗治疗移植相关性血栓性微血管病的疗效和安全性：系统评价和荟萃分析。
Front Immunol. 2021 Jan 20;11:564647. doi: 10.3389/fimmu.2020.564647. eCollection 2020.
8
Use of Eculizumab in Pediatric Patients With Transplant Associated Thrombotic Microangiopathy.依库珠单抗在儿童移植相关血栓性微血管病患者中的应用。
Front Pediatr. 2021 Nov 11;9:761726. doi: 10.3389/fped.2021.761726. eCollection 2021.
9
Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.依库珠单抗在日本儿童非典型溶血性尿毒症综合征患者中的安全性和有效性：上市后监测的中期分析
Clin Exp Nephrol. 2019 Jan;23(1):112-121. doi: 10.1007/s10157-018-1610-2. Epub 2018 Jul 23.
10
Eculizumab discontinuation in atypical haemolytic uraemic syndrome: TMA recurrence risk and renal outcomes.非典型溶血性尿毒症综合征中依库珠单抗的停药：血栓性微血管病复发风险及肾脏结局
Clin Kidney J. 2021 Jan 24;14(9):2075-2084. doi: 10.1093/ckj/sfab005. eCollection 2021 Sep.
本文引用的文献
1
"Eculizumab First" in the Management of Posttransplant Thrombotic Microangiopathy.依库珠单抗优先用于移植后血栓性微血管病的管理
Kidney Int Rep. 2024 Jan 10;9(4):982-993. doi: 10.1016/j.ekir.2024.01.013. eCollection 2024 Apr.
2
Thrombotic Microangiopathy After Kidney Transplantation: An Underdiagnosed and Potentially Reversible Entity.肾移植后血栓性微血管病：一种诊断不足且可能可逆的病症。
Front Med (Lausanne). 2021 Apr 8;8:642864. doi: 10.3389/fmed.2021.642864. eCollection 2021.
3
Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation.肾移植后补体突变相关的新发血栓性微血管病
Am J Transplant. 2008 Aug;8(8):1694-701. doi: 10.1111/j.1600-6143.2008.02297.x. Epub 2008 Jun 28.
4
Follow-up of kidney graft recipients with cyclosporine-associated hemolytic-uremic syndrome and thrombotic microangiopathy.接受环孢素相关溶血尿毒综合征和血栓性微血管病的肾移植受者的随访
Transplant Proc. 2005 May;37(4):1889-91. doi: 10.1016/j.transproceed.2005.02.112.
5
De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy.肾移植受者的新发血栓性微血管病：溶血性尿毒症综合征与局限性肾血栓性微血管病的比较
Am J Kidney Dis. 2003 Feb;41(2):471-9. doi: 10.1053/ajkd.2003.50058.
Zotero 插件